Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(18%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
7
64%
Ph phase_3
2
18%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Recruiting2
Not yet recruiting2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (22.2%)
N/A7 (77.8%)

Trials by Status

withdrawn19%
recruiting218%
completed545%
not_yet_recruiting218%
terminated19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11